Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4246646
Max Phase: Preclinical
Molecular Formula: C58H104N18O10
Molecular Weight: 1213.59
Molecule Type: Small molecule
Associated Items:
ID: ALA4246646
Max Phase: Preclinical
Molecular Formula: C58H104N18O10
Molecular Weight: 1213.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(N)cc1)C(N)=O)C(C)C
Standard InChI: InChI=1S/C58H104N18O10/c1-31(2)26-43(68-36(11)77)52(82)73-45(28-33(5)6)54(84)75-46(29-34(7)8)55(85)74-44(27-32(3)4)53(83)70-41(18-15-25-67-58(64)65)51(81)76-47(35(9)10)56(86)71-39(16-12-13-23-59)49(79)69-40(17-14-24-66-57(62)63)50(80)72-42(48(61)78)30-37-19-21-38(60)22-20-37/h19-22,31-35,39-47H,12-18,23-30,59-60H2,1-11H3,(H2,61,78)(H,68,77)(H,69,79)(H,70,83)(H,71,86)(H,72,80)(H,73,82)(H,74,85)(H,75,84)(H,76,81)(H4,62,63,66)(H4,64,65,67)/t39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1
Standard InChI Key: XMYNGUGMVGMFEP-CSYZDTNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1213.59 | Molecular Weight (Monoisotopic): 1212.8183 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):